Dosage, Feasibility, Acceptability and Usability of OTX-601

Led by Oui Therapeutics, Inc. · Updated on 2026-07-27

Participants Needed

Research Sites

N/A

Total Duration

AI-Summary

This study is exploring the efficacy of a digital therapeutic app in reducing symptoms of posttraumatic stress disorder (PTSD) in adults.

CONDITIONS

Feasibility of a Digital Therapeutic for Adults With Posttraumatic Stress Disorder (PTSD)

Age: 18Years +

All Genders

Inclusion Criteria:

Exclusion Criteria:

Score of 24 or lower on the ASI-3
Score of 30 and below on the PCL-5
No PTSD diagnosis
Active psychosis
Acute intoxication during study baseline
Enrolled in another treatment research study
Medical illness that would prevent the completion of interoceptive exposure exercises

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here